Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST BLOOMBERG GLOBAL SEMICONDUCTOR SUPPLY CHAIN UCITS ETF 26.05.2026 CHPS.LN IE000KXTLDE2 725,002.00 USD 36,007,216.96 49.665 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 26.05.2026 MISL.LN IE000NVDQXE1 4,025,002.00 USD 139,508,230.11 34.660 ...
-
Duco Launches the First Agentic Operations Platform for Financial Services
LONDON--(BUSINESS WIRE)--Duco, today launched the first agentic Operations platform for financial services. Built on the engine that already processes 20 billion transactions every month for more than 200 clients, including seven of the top 20 banks and ten of the top 20 asset managers, the platform brings together everything firms need to run post-trade Operations alongside autonomous agents, safely and at scale. The launch establishes a breakthrough the industry has been waiting for. A tool s...
-
Second Front Achieves NATO UNCLASSIFIED ATO, Deploys DIANA Mission-Critical Platform in 17 Days
LONDON--(BUSINESS WIRE)--Second Front Achieves NATO UNCLASSIFIED ATO, Deploys DIANA Mission-Critical Platform in 17 Days...
-
PipeChain übernimmt das niederländische Supply-Chain-Softwareunternehmen Quyntess, baut seine globale Präsenz aus und stärkt seine Kompetenzen im Bereich der durchgängigen Digitalisierung
STOCKHOLM--(BUSINESS WIRE)--PipeChain, ein globaler Anbieter von cloudbasierter Collaborative Planning & Execution-Software für große multinationale Unternehmen sowie von Multi-Enterprise-Netzwerklösungen für die Automobil- und Einzelhandelsbranche, gab heute die Übernahme des niederländischen Supply-Chain-Softwareunternehmens Quyntess Holding B.V. („Quyntess“, https://www.quyntess.com) bekannt, mit etablierten Niederlassungen in den Benelux-Ländern, Deutschland, Frankreich und den USA. Das...
-
PipeChain neemt Nederlands supply chain-softwarebedrijf Quyntess over, breidt wereldwijde positie uit en versterkt end-to-end digitaliseringsmogelijkheden
STOCKHOLM--(BUSINESS WIRE)--PipeChain, een wereldwijde leverancier van cloudgebaseerde Collaborative Planning & Execution-software voor grote multinationale ondernemingen en Multi-Enterprise Network-oplossingen voor de automotive- en retailsector, heeft vandaag de overname aangekondigd van het Nederlandse supply chain-softwarebedrijf Quyntess Holding B.V. (“Quyntess”, https://www.quyntess.com/), met operaties in de Benelux, Duitsland, Frankrijk en de Verenigde Staten. De gecombineerde organ...
-
PipeChain Acquires Dutch Supply Chain Software Company Quyntess, Expanding Global Footprint and Strengthening End-to-End Digitalization Capabilities
STOCKHOLM--(BUSINESS WIRE)--PipeChain, a global provider of cloud-based Collaborative Planning & Execution software for large multinational companies and Multi-Enterprise Network solutions for the automotive and retail industries, today announced the acquisition of the Dutch supply chain software company Quyntess Holding B.V. (“Quyntess”, https://www.quyntess.com/) with established operations in the Benelux region, Germany, France, and the United States. The combined entity will reach sales...
-
mimik Launches mimOE Studio to Accelerate Agentix-Native Systems with Sustainable Economics and Scalable Growth
OAKLAND, Calif.--(BUSINESS WIRE)--mimOE Studio, the first Agentix-Native Workstation, enabling enterprises to build, operate and scale agents with certainty....
-
Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)
LYON, France--(BUSINESS WIRE)--Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, whi...
-
Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced the presentation of new and late-breaking clinical data from the ELIMINATE-B study evaluating PBGENE-HBV at the European Association for the Study of the Liver (EASL) Annual Congress 2026. The late-breaking data, titled ‘First evidence of elimination...